Search

everythinglearnresearchcommunity

for

Search:↓

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

3D imaging effectively tracks skin changes in vitiligo treatment.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

High doses of cobalt stopped hair growth in rabbits.

Finasteride affects the male rat brain by reducing certain protein activation, but these effects may reverse after stopping the drug.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Tideglusib may help bone regeneration without being toxic at low doses.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

A new combination of tadalafil and finasteride improves drug performance and stability.

Fucoidan may help regrow hair and reduce inflammation in hair loss.

Ritlecitinib is safe and may effectively treat alopecia areata.

Early detection and biotin treatment improve outcomes for biotinidase deficiency.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

FGF18 is present in beagle dog hair follicles, mainly in the inner root sheath.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

A patient with complete hair loss regrew all her hair using tofacitinib.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

FOL-005 peptide can reduce human hair growth by lowering FGF7 levels.

Antifungal treatment reduced asthma exacerbations and corticosteroid use but its overall benefit is unclear.